Medicine Active substance Licence holder Status
Almogran 12.5 mg film-coated tablet PA0968/001/001
Almotriptan
Almirall, S.A.
Marketed
Ebglyss 250 mg solution for injection in pre-filled pen EU/1/23/1765/007-012
Lebrikizumab
Almirall, S.A.
—
Ebglyss 250 mg solution for injection in pre-filled syringe EU/1/23/1765/001-006
Lebrikizumab
Almirall, S.A.
—
Ilumetri EU/1/18/1323/001
Tildrakizumab
Almirall, S.A.
—
Ilumetri 200 mg solution for injection in pre-filled syringe EU/1/18/1323/003
Tildrakizumab
Almirall S.A.
—
Klisyri 10 mg/g ointment EU/1/21/1558/001
Tirbanibulin
Almirall, S.A.
—
Meptid 100 mg/ml Solution for Injection PA0968/005/001
Meptazinol
Almirall, S.A.
Not marketed
Meptid 200 mg film-coated Tablets PA0968/005/002
Meptazinol
Almirall, S.A.
Marketed
Prometax 1.5 mg hard capsules EU/1/98/092/001-003
Rivastigmine hydrogen tartrate
Almirall, S.A.
—
Prometax 13.3 mg/24 h transdermal patch EU/1/98/092/027-030
Rivastigmine
Almirall, S.A.
—
Prometax 2 mg/ml oral solution EU/1/98/092/013
Rivastigmine hydrogen tartrate
Almirall, S.A.
—
Prometax 3.0 mg hard capsules EU/1/98/092/004-006
Rivastigmine hydrogen tartrate
Almirall, S.A.
—
Prometax 4.5 mg hard capsules EU/1/98/092/007-009
Rivastigmine hydrogen tartrate
Almirall, S.A.
—
Prometax 4.6 mg/24 h transdermal patch EU/1/98/092/19-22
Rivastigmine
Almirall, S.A.
—
Prometax 6.0 mg hard capsules EU/1/98/092/010-012
Rivastigmine hydrogen tartrate
Almirall, S.A.
—
Prometax 9.5 mg/24 h transdermal patch EU/1/98/092/23-26
Rivastigmine
Almirall, S.A.
—
Skilarence 120 mg gastro-resistant tablets EU/1/17/1201/002-011
Dimethyl Fumarate
Almirall, S.A.
—
Skilarence 30 mg gastro-resistant tablets EU/1/17/1201/001
Dimethyl Fumarate
Almirall, S.A.
—
Solaraze 3% gel PA0968/004/001
Diclofenac sodium
Almirall, S.A.
Marketed
Vaniqa 11.5% EU/1/01/173/002
Eflornithine
Almirall, S.A.
—
Vaniqa 11.5% EU/1/01/173/003
Eflornithine
Almirall, S.A.
—
Vaniqa 11.5% cream EU/1/01/173/001
Eflornithine
Almirall, S.A.
—
Wynzora 50 micrograms/g + 0.5 mg/g cream PA0968/006/001
Calcipotriol, Betamethasone
Almirall, S.A.
Not marketed
Cite this database
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 11 September 2026).
Copy citation
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy .
Essential only
Accept all